Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Venzon, David J."'
Autor:
Aoki, Manabu1,2, Venzon, David J.3, Koh, Yasuhiro1, Aoki-Ogata, Hiromi1, Miyakawa, Toshikazu1, Yoshimura, Kazuhisa1, Maeda, Kenji1,4, Mitsuya, Hiroaki1,4 hm21q@nih.gov
Publikováno v:
Journal of Virology. Apr2009, Vol. 83 Issue 7, p3059-3068. 10p.
Autor:
Musich, Thomas1,2, Thovarai, Vishal3, Venzon, David J.4, Mohanram, Venkatramanan1,5, Tuero, Iskra1,6, Miller-Novak, Leia K.1,7, Hait, Sabrina Helmold1, Rahman, Mohammad Arif1, Hunegnaw, Ruth1, Huiting, Erin1, Yuan, Wuxing3, O'huiting, Colm3,8, Tanya Hoang1, Yongjun Sui9, LaBranche, Celia10, Montefiori, David10, Bear, Jenifer11, Rosati, Margherita12, Bissa, Massimiliano13, Berzofsky, Jay A.9
Publikováno v:
Journal of Virology. 2020, Vol. 94 Issue 24, p1-26. 26p.
Autor:
de Castro, Isabela Silva1, Gordon, Shari N.1, Jun Liu2,3, Bissa, Massimiliano1, McKinnon, Katherine4, Trinh, Hung V.5,6, Doster, Melvin N.1, Schifanella, Luca1, Liyanage, Namal P.1, JinChao Cao2,3, Olivia Cheng2,3, Foulds, Kathryn7, Roederer, Mario7, Koup, Richard A.7, Xiaoying Shen8, Tomaras, Georgia D.8, Venzon, David J.9, Forthal, Donald N.10, Fouts, Timothy11, Montefiori, David C.8
Publikováno v:
Journal of Virology. Mar2020, Vol. 94 Issue 6, p1-20. 20p.
Autor:
Hait, Sabrina Helmold1, Vargas-Inchaustegui, Diego A.1, Musich, Thomas1,2, Mohanram, Venkatramanan1, Tuero, Iskra1,3, Venzon, David J.4, Bear, Jenifer5, Rosati, Margherita6, Vaccari, Monica7, Franchini, Genoveffa7, Felber, Barbara K.5, Pavlakis, George N.6, Robert-Guroff, Marjorie1 guroffm@mail.nih.gov
Publikováno v:
Journal of Virology. Feb2019, Vol. 93 Issue 4, p1-22. 22p.
Autor:
Miller-Novak, Leia K.1,2, Das, Jishnu3, Musich, Thomas A.1,4, Demberg, Thorsten1,5, Weiner, Joshua A.6, Venzon, David J.7, Mohanram, Venkatramanan1, Vargas-Inchaustegui, Diego A.1, Tuero, Iskra1,8, Ackerman, Margaret E.6, Alter, Galit3, Robert-Guroff, Marjorie1 guroffm@mail.nih.gov
Publikováno v:
Journal of Virology. Oct2018, Vol. 92 Issue 19, p1-56. 56p.
Autor:
Sangare K; Department of Biology, Howard University, Washington, DC, USA., Tuero I; Section on Immune Biology of Retroviral Infection, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Rahman MA; Section on Immune Biology of Retroviral Infection, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Hoang T; Section on Immune Biology of Retroviral Infection, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Miller-Novak LK; Section on Immune Biology of Retroviral Infection, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Vargas-Inchaustegui DA; Section on Immune Biology of Retroviral Infection, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Venzon DJ; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., LaBranche C; Duke University Medical Center, Durham, North Carolina, USA., Montefiori DC; Duke University Medical Center, Durham, North Carolina, USA., Robert-Guroff M; Section on Immune Biology of Retroviral Infection, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Thomas MA; Department of Biology, Howard University, Washington, DC, USA michael.thomas1@howard.edu.
Publikováno v:
Journal of virology [J Virol] 2021 Mar 10; Vol. 95 (7). Date of Electronic Publication: 2021 Jan 13.
Autor:
Silva de Castro I; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gordon SN; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Liu J; Department of Medicine, University of Toronto, Toronto, Canada.; Keenan Research Center, St. Michael's Hospital, Toronto, Canada., Bissa M; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., McKinnon K; Vaccine Branch Flow Cytometry Core, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Trinh HV; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA., Doster MN; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schifanella L; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Liyanage NP; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Cao J; Department of Medicine, University of Toronto, Toronto, Canada.; Keenan Research Center, St. Michael's Hospital, Toronto, Canada., Cheng O; Department of Medicine, University of Toronto, Toronto, Canada.; Keenan Research Center, St. Michael's Hospital, Toronto, Canada., Foulds K; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA., Roederer M; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA., Koup RA; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA., Shen X; Department of Surgery, Duke Human Vaccine Institute, Durham, North Carolina, USA., Tomaras GD; Department of Surgery, Duke Human Vaccine Institute, Durham, North Carolina, USA., Venzon DJ; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Forthal DN; University of California, Irvine School of Medicine, Irvine, California, USA., Fouts T; Advanced Bioscience Laboratories, Rockville, Maryland, USA., Montefiori DC; Department of Surgery, Duke Human Vaccine Institute, Durham, North Carolina, USA., Tartaglia J; Sanofi Pasteur, Swiftwater, Pennsylvania, USA., Rao M; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA., Ostrowski M; Department of Medicine, University of Toronto, Toronto, Canada.; Keenan Research Center, St. Michael's Hospital, Toronto, Canada., Franchini G; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA franchig@mail.nih.gov vaccarim@mail.nih.gov., Vaccari M; Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA franchig@mail.nih.gov vaccarim@mail.nih.gov.
Publikováno v:
Journal of virology [J Virol] 2020 Feb 28; Vol. 94 (6). Date of Electronic Publication: 2020 Feb 28 (Print Publication: 2020).
Autor:
Higashi-Kuwata N; Department of Refractory Viral Infections, National Center for Global Health & Medicine Research Institute, Tokyo, Japan., Hayashi S; Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Das D; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Kohgo S; Department of Refractory Viral Infections, National Center for Global Health & Medicine Research Institute, Tokyo, Japan., Murakami S; Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Hattori SI; Department of Refractory Viral Infections, National Center for Global Health & Medicine Research Institute, Tokyo, Japan., Imoto S; Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan., Venzon DJ; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Singh K; Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Sarafianos SG; Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Tanaka Y; Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health & Medicine Research Institute, Tokyo, Japan hiroaki.mitsuya2@nih.gov.; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Mar 27; Vol. 63 (4). Date of Electronic Publication: 2019 Mar 27 (Print Publication: 2019).
Autor:
Helmold Hait S; Immune Biology of Retroviral Infection Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA., Vargas-Inchaustegui DA; Immune Biology of Retroviral Infection Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA., Musich T; Immune Biology of Retroviral Infection Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA., Mohanram V; Immune Biology of Retroviral Infection Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA., Tuero I; Immune Biology of Retroviral Infection Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA., Venzon DJ; Biostatistics and Data Management Section, NCI, NIH, Bethesda, Maryland, USA., Bear J; Human Retrovirus Pathogenesis Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, USA., Rosati M; Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, USA., Vaccari M; Animal Models and Retroviral Vaccines Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA., Franchini G; Animal Models and Retroviral Vaccines Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA., Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, USA., Pavlakis GN; Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, USA., Robert-Guroff M; Immune Biology of Retroviral Infection Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA guroffm@mail.nih.gov.
Publikováno v:
Journal of virology [J Virol] 2019 Feb 05; Vol. 93 (4). Date of Electronic Publication: 2019 Feb 05 (Print Publication: 2019).
Autor:
Singh S; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Ramírez-Salazar EG; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Doueiri R; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Valentin A; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Rosati M; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Hu X; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Keele BF; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Shen X; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Tomaras GD; Duke Human Vaccine Institute, Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.; Duke Human Vaccine Institute, Department of Molecular Genetics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Human Vaccine Institute, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Ferrari G; Duke Human Vaccine Institute, Department of Molecular Genetics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Human Vaccine Institute, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., LaBranche C; Duke Human Vaccine Institute, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Montefiori DC; Duke Human Vaccine Institute, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Das J; Ragon Institute of MGH, MIT, and Harvard University, Cambridge, Massachusetts, USA., Alter G; Ragon Institute of MGH, MIT, and Harvard University, Cambridge, Massachusetts, USA., Trinh HV; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA., Hamlin C; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA., Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA., Dayton F; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Bear J; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Chowdhury B; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Alicea C; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA., Lifson JD; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Broderick KE; Inovio Pharmaceuticals, Inc., Plymouth Meeting, Pennsylvania, USA., Sardesai NY; Inovio Pharmaceuticals, Inc., Plymouth Meeting, Pennsylvania, USA., Sivananthan SJ; Infectious Disease Research Institute, Seattle, Washington, USA., Fox CB; Infectious Disease Research Institute, Seattle, Washington, USA., Reed SG; Infectious Disease Research Institute, Seattle, Washington, USA., Venzon DJ; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA., Hirsch VM; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Pavlakis GN; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA George.pavlakis@nih.gov Barbara.felber@nih.gov., Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA George.pavlakis@nih.gov Barbara.felber@nih.gov.
Publikováno v:
Journal of virology [J Virol] 2018 Jul 17; Vol. 92 (15). Date of Electronic Publication: 2018 Jul 17 (Print Publication: 2018).